However, unexpectedly, when NK-92 cells were cocultured with NK-92-sensitive cells, almost all the cells (>95%) were CD56-positive, suggesting that the NK-92-sensitive breast cancer cells would express the adhesion molecule CD56. This evidence concerns the gene NCAM1 and breast carcinoma.